CA266-0004: A Randomized Phase 2/3 Study of BMS-986545-01 (BNT327) in Combination with Chemotherapy Versus Standard of Care in Previously Untreated Participants with Unresectable, Metastatic, or Advanced Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Principal Investigator

Dr Elizabeth Smyth

Contact us

Email: orh-tr.earlyphasenurses@nhs.net

IRAS number

1013196